Andrew Aschenbrenner

Keyphrases

1. Alzheimer's Disease 100%
2. Older Adults 63%
3. Sporadic Alzheimer's Disease 51%
4. Cerebrospinal Fluid 38%
5. Attentional Control 30%
6. Dominantly Inherited Alzheimer's Disease 30%
7. Healthy Aging 28%
8. Autosomal Dominant Alzheimer's Disease 27%
9. Cognitive Decline 26%
10. Alzheimer's Disease Pathology 25%
11. Dominantly Inherited Alzheimer Network 25%
12. Episodic Memory 22%
13. Cerebrospinal Fluid Biomarkers 21%
14. Longitudinal Change 20%
15. Cognitive Assessment 17%
16. Clinical Trials 17%
17. Cognitively Normal 16%
18. Processing Speed 15%
19. Tau PET 15%
20. Solanezumab 15%
21. Gantenerumab 15%
22. Dynamic Adjustment 15%
23. Early Alzheimer's Disease 14%
24. Congruency Sequence Effect 14%
25. Lexical Decision Task 14%
26. Dementia 14%
27. Alzheimer's Disease Biomarkers 13%
28. Cognitive Change 13%
29. Mutation Carriers 13%
30. Hippocampal Volume 13%
31. Symptom Onset 12%
32. Conscientiousness 12%
33. Healthy Adults 12%
34. Working Memory 12%
35. Neurofilament Light (NF-L) 12%
36. Clinical Dementia Rating 11%
37. Imaging Biomarkers 11%
38. Mild Alzheimer's Disease 11%
39. Cognitive Impairment 11%
40. Word Frequency 11%
41. Cognitive Measures 11%
42. Amyloid Positron Emission Tomography 10%
43. Additive Effect 10%
44. Cognitive Composite 10%
45. Down Syndrome 9%
46. Adults at Risk 9%
47. Stimulus Quality 9%
48. Driving Behavior 9%
49. Trial History 9%
50. Diffusion Model Analysis 9%